证券记录 · 已归档季度
INCY
Incyte Corporation · Healthcare · Biotechnology
17被追踪持有人
—Δ持有人
33.47M持有股份
$2.03B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 156 | 0 | 132.86M | $15.06B | +4 | −3 |
| Q1 2026 | 158 | +1 | 132.61M | $12.47B | +5 | −5 |
| Q4 2025 | 156 | -1 | 139.13M | $13.74B | +1 | −1 |
| Q3 2025 | 24 | 0 | 89.63M | $7.60B | — | −1 |
| Q2 2025 | 22 | +1 | 88.20M | $6.01B | +1 | — |
| Q1 2025 | 18 | -1 | 44.33M | $2.68B | — | −1 |
| Q4 2024 | 19 | +1 | 43.85M | $3.03B | +1 | — |
| Q3 2024 | 17 | 0 | 35.50M | $2.35B | +1 | −1 |
| Q2 2024 | 17 | — | 33.47M | $2.03B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 15.28M | — | $926.23M | 0.6% | n/c | 1 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 5.22M | — | $316.34M | 0.5% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 4.05M | — | $244.63M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 4.05M | — | $244.63M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 2.66M | — | $159.91M | 0.2% | n/c | 1 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 2.66M | — | $159.91M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 2.66M | — | $159.91M | 0.2% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 2.66M | — | $159.91M | 0.2% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 2.66M | — | $159.91M | 0.2% | n/c | 1 | SEC ↗ |
| 10 | Norges Bank ✦ (被动) | 2.12M | — | $128.77M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.23M | — | $74.76M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.23M | — | $74.76M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 821.67K | — | $49.81M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 821.67K | — | $49.81M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 420.30K | — | $25.48M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | ARK Investment Management ✦ | 398.66K | — | $24.17M | 0.2% | n/c | 1 | SEC ↗ |
| 17 | Capital World Investors ✦ | 396.00K | — | $24.01M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 225.11K | — | $13.65M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 225.11K | — | $13.65M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 218.08K | — | $13.22M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Wellington Management ✦ | 174.83K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Wellington Management ✦ | 174.83K | — | $10.60M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 127.13K | — | $7.71M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 80.14K | — | $4.86M | 0.1% | n/c | 1 | SEC ↗ |
| 25 | Marshall Wace ✦ | 33.54K | — | $2.03M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Fisher Asset Management ✦ | 9.26K | — | $561,256 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 805 持有人, 201.47M 股份, $18.13B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
CAGNONI PABLO J
Officer · 10.80K 股 · $1.36M
Aug 12
CAGNONI PABLO J
Officer · 10.80K 股 · $1.30M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据